{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:44:06Z","timestamp":1789811046837,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1741-7015-11-182","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T10:42:48Z","timestamp":1376563368000},"source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: results from an open-label clinical trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Tatsufumi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Nagasato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Narita-Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"1090_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/aid.1993.9.381","volume":"9","author":"G De-Th\u00e9","year":"1993","unstructured":"De-Th\u00e9 G, Bomford R: An HTLV-I vaccine: why, how, for whom?. AIDS Res Hum Retroviruses. 1993, 9: 381-386.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1090_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199304223281608","volume":"328","author":"P Hollsberg","year":"1993","unstructured":"Hollsberg P, Hafler DA: Pathogenesis of diseases induced by human T-lymphotropic virus type I infection. N Engl J Med. 1993, 328: 1173-1182.","journal-title":"N Engl J Med"},{"key":"1090_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","volume":"19","author":"M Yoshida","year":"2001","unstructured":"Yoshida M: Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol. 2001, 19: 475-496.","journal-title":"Annu Rev Immunol"},{"key":"1090_CR4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"8488","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new entity. Lancet. 1986, 8488: 1031-1032.","journal-title":"Lancet"},{"key":"1090_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.410210203","volume":"21","author":"M Osame","year":"1987","unstructured":"Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol. 1987, 21: 117-122.","journal-title":"Ann Neurol"},{"key":"1090_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/187152409788452090","volume":"9","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Nishiura Y, Eguchi K: Therapeutic strategies in HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Cent Nerv Syst Agents Med Chem. 2009, 9: 137-149.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"1090_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0022-510X(91)90192-A","volume":"106","author":"J Kira","year":"1991","unstructured":"Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K: Leukoencephalopathy in HTLV-I-associated myelopathy\/tropical spastic paraparesis: MRI analysis and a 2 year follow-up study after corticosteroid therapy. J Neurol Sci. 1991, 106: 41-49.","journal-title":"J Neurol Sci"},{"key":"1090_CR8","first-page":"182","volume":"47","author":"T Nakamura","year":"2009","unstructured":"Nakamura T: HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Folia Neuropathol. 2009, 47: 182-194.","journal-title":"Folia Neuropathol"},{"key":"1090_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.jbchem.a126421","volume":"41","author":"M Fujiwara","year":"1954","unstructured":"Fujiwara M, Watanabe H, Matsui K: \u201cAllithiamine\u201d a newly found derivative of vitamine B1. I. discovery of allithiamine. J Biochem (Tokyo). 1954, 41: 29-39.","journal-title":"J Biochem (Tokyo)"},{"key":"1090_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2183\/pjab1945.28.146","volume":"28","author":"T Matsukawa","year":"1952","unstructured":"Matsukawa T, Yurugi S: On the structure of allithiamine. Proc Japan Acad. 1952, 28: 146-149.","journal-title":"Proc Japan Acad"},{"key":"1090_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/135965350901400412","volume":"14","author":"Y Nishiura","year":"2009","unstructured":"Nishiura Y, Nakamura T, Fukushima N, Nakamura H, Ida H, Aramaki T, Eguchi K: Disulfide-mediated apoptosis of human T-lymphotropic virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. Antivir Ther. 2009, 14: 533-542.","journal-title":"Antivir Ther"},{"key":"1090_CR12","first-page":"191","volume-title":"Human Retrovirology: HTLV","author":"M Osame","year":"1990","unstructured":"Osame M: Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP. Human Retrovirology: HTLV. Edited by: Blattner WA. 1990, New York, NY: Raven, 191-197."},{"key":"1090_CR13","first-page":"213","volume-title":"HTLV-I and the Nervous System","author":"M Osame","year":"1989","unstructured":"Osame M, Igata A, Matsumoto M: HTLV-I-associated myelopathy (HAM) revisited. HTLV-I and the Nervous System. Edited by: Rom\u00e1n GC, Vernant J-C, Osame M. 1989, New York, NY: Alan R, Liss, Inc, 213-223."},{"key":"1090_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"RW Bohannon","year":"1987","unstructured":"Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987, 67: 206-207.","journal-title":"Phys Ther"},{"key":"1090_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.urology.2003.10.019","volume":"63","author":"L Abraham","year":"2004","unstructured":"Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, MacDonaqh RP, Noble JG: Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004, 63: 481-486.","journal-title":"Urology"},{"key":"1090_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.urology.2005.10.054","volume":"67","author":"HJ Yu","year":"2006","unstructured":"Yu HJ, Chen FY, Huang PC, Chen THH, Chie WC, Liu CY: Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology. 2006, 67: 713-718.","journal-title":"Urology"},{"key":"1090_CR17","first-page":"833","volume":"23","author":"M Yoshida","year":"2010","unstructured":"Yoshida M, Ikeda S: Development of the Japanese version of the nocturia quality of life questionnaire (N-QOL) [in Japanese]. Jpn J Urol Surg. 2010, 23: 833-838.","journal-title":"Jpn J Urol Surg"},{"key":"1090_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2036.2006.02774.x","volume":"23","author":"SJO Veldhuyzen Van Zanten","year":"2006","unstructured":"Veldhuyzen Van Zanten SJO, Chiba N, Armstrong D, Barkun AN, Thomson ABR, Mann V, Escobedo S, Chakraborty B, Nevin K: Validation of a 7-point global overall symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006, 23: 521-529.","journal-title":"Aliment Pharmacol Ther"},{"key":"1090_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1590\/S1807-59322007000200015","volume":"62","author":"P Oliveira","year":"2007","unstructured":"Oliveira P, Castro NM, Carvalho EM: Urinary and sexual manifestations of patients infected by HTLV-1. Clinics. 2007, 62: 191-196.","journal-title":"Clinics"},{"key":"1090_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.urology.2007.01.052","volume":"69","author":"NM Castro","year":"2007","unstructured":"Castro NM, Rodrigues W, Freitas DM, Muniz A, Oliveira P, Carvalho EM: Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers. Urology. 2007, 69: 813-818.","journal-title":"Urology"},{"key":"1090_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-4690-3-63","volume":"3","author":"GP Taylor","year":"2006","unstructured":"Taylor GP, Goon P, Furukawa Y, Green H, Barfield A, Mosley A, Nose H, Babiker A, Rudge P, Usuku K, Osame M, Bangham CRM, Weber JN: Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: a randomized trial. Retrovirology. 2006, 3: 63.","journal-title":"Retrovirology"},{"key":"1090_CR22","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1182\/blood-2011-04-349910","volume":"118","author":"S Olindo","year":"2011","unstructured":"Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, Verlaeten O, Asquith B, Bangham C, Signat\u00e9 A, Smadja D, Lezin A, C\u00e9saire R, Willems L: Safety of long-term treatment of HAM\/TSP patients with valproic acid. Blood. 2011, 118: 6306-6309.","journal-title":"Blood"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-11-182\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:33:42Z","timestamp":1688420022000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-11-182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1090"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-11-182","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]},"article-number":"182"}}